Evidence map›Paper›PMID 34948180›Full record

ReviewInternational journal of molecular sciences2021

Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases.

Paweł Kowalczyk, Dorota Sulejczak, Patrycja Kleczkowska, Iwona Bukowska-Ośko, Marzena Kucia, Marta Popiel, Ewa Wietrak, Karol Kramkowski, Karol Wrzosek, Katarzyna Kaczyńska

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05936528 (The Effect of Lactoferrin in Improving Clinical Outcomes in ICU Patients), which is not on this map. Cited by 281 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
281citing papers in PubMed, 1 pooled it
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05936528 phase4completednot on this mapstarted 2025, after this paper: background citation

The Effect of Lactoferrin in Improving Clinical Outcomes in ICU Patients

TypeinterventionalSponsorMansoura University HospitalRan2025 to 2026Enrolled660ConditionsCritical IllnessArmsLactoferrin, Antioxidant therapies, Dexamethasone, Antibacterial therapies
3 · Its place in the literature

Who cites it

281 citing papers in PubMed, 1 synthesis or guideline pooled it, 418 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. A HeterogeneousInternational journal of molecular sciences · 2026
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

221 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Paweł KowalczykDepartment of Animal Nutrition, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland.ORCID 0000-0003-4025-3750
Dorota SulejczakDepartment of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.ORCID 0000-0002-1697-8164
Patrycja KleczkowskaAnalytical Group, Department of Analytical Chemistry and Biomaterials, Faculty of Pharmacy with Laboratory Medicine Division, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0002-8389-0920
Iwona Bukowska-OśkoDepartment of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.
Marzena KuciaR&D Department Nutropharma LTD, Jedności 10A, 05-506 Lesznowola, Poland.
Marta PopielDepartment of Animal Nutrition, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland.
Ewa WietrakR&D Department Nutropharma LTD, Jedności 10A, 05-506 Lesznowola, Poland.
Karol KramkowskiDepartment of Physical Chemistry, Medical University of Bialystok, Kilińskiego 1 Str., 15-089 Białystok, Poland.
Karol WrzosekDepartment of Heart Diseases, The Medical Center of Postgraduate Education, Marymoncka 99/103, 01-813 Warsaw, Poland.
Katarzyna KaczyńskaDepartment of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.ORCID 0000-0001-9608-4736
Kielanowski Institute of Animal Physiology and Nutrition · PLMedical University of Warsaw · PLMossakowski Medical Research Institute, Polish Academy of Sciences · PLMedical University of Białystok · PLPostgraduate School of Molecular Medicine · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The excessive formation of reactive oxygen species (ROS) and impairment of defensive antioxidant systems leads to a condition known as oxidative stress. The main source of free radicals responsible for oxidative stress is mitochondrial respiration. The deleterious effects of ROS on cellular biomolecules, including DNA, is a well-known phenomenon that can disrupt mitochondrial function and contribute to cellular damage and death, and the subsequent development of various disease processes. In this review, we summarize the most important findings that implicated mitochondrial oxidative stress in a wide variety of pathologies from Alzheimer disease (AD) to autoimmune type 1 diabetes. This review also discusses attempts to affect oxidative stress as a therapeutic avenue.

Indexed as

AnimalsAntioxidantsDiseaseFree RadicalsHumansMitochondriaMitochondrial DiseasesOxidative StressReactive Oxygen SpeciesAntioxidantsFree RadicalsReactive Oxygen Speciesantioxidant therapymitochondriamitochondrial diseasesoxidative stress

Identifiers

PMID34948180
PMCPMC8707347
OpenAlexW4200119598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.